Catheter Precision, Inc. has entered into an At Market Offering Agreement with Ladenburg Thalmann & Co. Inc., allowing the company to offer and sell up to $1.3 million of its common stock. The shares will be issued under the company's existing Registration Statement on Form S-3. The proceeds from this offering are intended to fund operations and serve as working capital. The agreement, which can be terminated by either party with five days' notice, stipulates a 3% commission for Ladenburg on the aggregate gross proceeds from each stock sale.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.